Kenneth Escoe joins Ingredion (NYSE: INGR) board Audit Committee
Rhea-AI Filing Summary
Ingredion Incorporated reported that on July 28, 2026, its Board of Directors appointed recently elected director Kenneth Escoe to serve on the Audit Committee. Escoe was previously elected to the board in a disclosure dated June 7, 2026, and this amendment updates that disclosure solely to reflect his committee assignment.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Appointment date: July 28, 2026
Director election disclosure date: June 7, 2026
Original report filing date: June 11, 2026
+1 more
4 metrics
Appointment date
July 28, 2026
Date Kenneth Escoe was appointed to the Audit Committee
Director election disclosure date
June 7, 2026
Date of earlier disclosure announcing election of Kenneth Escoe as director
Original report filing date
June 11, 2026
Date the company filed the earlier director-election report
Company telephone
(708) 551-2600
Registrant’s telephone number including area code
Key Terms
Audit Committee, Board of Directors, Item 5.02, Section 13 or 15(d) of the Securities Exchange Act of 1934
4 terms
Audit Committee regulatory
"appointed Mr. Escoe as a member of the Audit Committee of the Board of Directors"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Board of Directors regulatory
"appointed Mr. Escoe as a member of the Audit Committee of the Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers; Election of Directors"
Section 13 or 15(d) of the Securities Exchange Act of 1934 regulatory
"Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What corporate change does Ingredion (INGR) report in this 8-K/A?
Ingredion reports that director Kenneth Escoe has been appointed to its Audit Committee effective July 28, 2026. This updates a prior June 7, 2026 board-election disclosure and does not introduce any additional management or governance changes.
When did Ingredion (INGR) appoint Kenneth Escoe to the Audit Committee?
The Board appointed Kenneth Escoe to the Audit Committee on July 28, 2026. This committee assignment follows his earlier election as a director, which had been reported in a disclosure dated June 7, 2026 and filed on June 11, 2026.
Was Kenneth Escoe already a director of Ingredion (INGR) before this amendment?
Yes. Kenneth Escoe had already been elected as a director in a disclosure dated June 7, 2026. The new report does not change his directorship; it only adds his role as a member of the Audit Committee of the Board of Directors.
Does the Ingredion (INGR) 8-K/A report any other management or board changes?
No additional changes are reported beyond Escoe’s Audit Committee appointment. The company states that, except for adding this committee assignment information, there is no change to the prior June 7, 2026 board-election disclosure.
What SEC item is referenced in Ingredion’s (INGR) latest disclosure?
The disclosure is made under Item 5.02, covering departures or elections of directors, officer appointments, and compensatory arrangements. Here it is used specifically to report the committee assignment of existing director Kenneth Escoe to the Audit Committee.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(708 ) 551-2600
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(d) On June 11, 2026, Ingredion Incorporated (the “Company”) filed a Current Report on Form 8-K, dated June 7, 2026, announcing the election of Kenneth Escoe as a director of the Company.
On July 28, 2026, the Company’s Board of Directors appointed Mr. Escoe as a member of the Audit Committee of the Board of Directors. Except for the addition of this information, there is no change in the Current Report on Form 8-K dated June 7, 2026.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: July 29, 2026 | Ingredion Incorporated | ||||||||||||||||||||||||||||
| By: | /s/ Tanya M. Jaeger de Foras | ||||||||||||||||||||||||||||
Tanya M. Jaeger de Foras Senior Vice President, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer | |||||||||||||||||||||||||||||